COPD market expected to grow to $30.8bn in the 7MM by 2033
Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.
How ‘green’ inhalers could evade Biden’s drug pricing legacy
The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...
PharmiWeb4d
HONEYWELL TECHNOLOGY TO POWER DEVPRO BIOPHARMA’S NEXT-GENERATION LOW-EMISSION RESPIRATORY INHALER
Honeywell Solstice® Air can cut metered dose inhaler greenhouse gas emissions of up to 99.9% versus current propellants1 CHARLOTTE, N.C., October, 2024 – Honeywell (NASDAQ: HON) today announced a long ...
Transpire Bio Strengthens Leadership Team with New Appointments to Lead Commercialization, Quality Assurance, and Manufacturing
Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for ...
Armed robbery in Revesby1d
Half of Patients Miss New Lung Disease Standard
One in 13 Australians over the age of 40 have chronic obstructive pulmonary disease (COPD), but alarmingly only half of them know they have ...
Hosted on MSN15h
Chronic obstructive pulmonary disease market to hit $30.8b by 2033
Its growth is attributed to the introduction of new treatments. The chronic obstructive pulmonary disease (COPD) market is ...
Le Lézard1d
Modivcare and Tenovi Partner to Advance Respiratory Care, Lower Hospitalizations, and Cut Costs with Adherium's Hailie® Smart Inhalers
Modivcare Inc., a leading technology-enabled healthcare services company that provides a platform of integrated supportive care solutions, through its wholly owned subsidiaries, Valued Relationships, ...
Nursing in Practice2d
Government launches ‘major crackdown’ on NHS waste
The government has launched what it has described as a ‘major crackdown’ to reduce the number of single-use medical devices.
standardmedia.co.ke3d
Inhalers: Lifesavers for asthma, but hidden environmental threat
AstraZeneca recently announced the completion of clinical studies for a next-generation propellant (NGP) version of its chronic obstructive pulmonary disease (COPD) inhaler, Breztri. This new ...